Thermo Fisher Scientific (San Jose, California) announced that it will be hosting a series of seminars that demonstrate the company?s expertise in food safety.
Thermo Fisher Scientific (San Jose, California) announced that it will be hosting a series of seminars that demonstrate the company’s expertise in food safety. The global seminar program will take place across the U.S., Canada, Europe, Southeast Asia, and Japan from September 2009 through December 2009 and will offer participants information about food safety and the latest advances in the field. Program content will include global regulatory information, technology discussions, and practical suggestions for food safety professionals. Topics will include global perspectives on food safety, improving method performance to comply with new regulatory requirements, and the simplification of multiresidue analysis methods for pesticides and veterinary drug residues. Other presentations will cover new technologies to improve laboratory productivity, such as high-resolution mass spectrometry, and how the techniques can overcome emerging risks and threats to the food supply. More information about dates, locations, and registration can be found at www.thermo.com/foodsafety.
New Study Examines PFAS in Breast Milk Using LC-MS/MS
November 5th 2024On the suggestion that per- and polyfluoroalkyl substances (PFAS) affect both lactation and the human metabolome, perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) were measured in the milk of 425 participants from the New Hampshire Birth Cohort Study using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.